Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling

Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling

10.1016/j.canlet.2017.12.030

Saved in:
Bibliographic Details
Main Authors: Wang, Lingzhi, Syn, Nicholas Li-Xun, Subhash, Vinod Vijay, Any, Yijia, Thuya, Win Lwin, Cheow, Esther Sok Hwee, Kong, Li Ren, Yu, Fenggang, Peethala, Praveen C., Wong, Andrea Li-Ann, Laljibhai, Hirpara J., Chinnathambi, Arunachalam, Ong, Pei Shi, Ho, Paul Chi-Lui, Sethi, Gautam, Yong, Wei Peng, Goh, Boon Cher
Other Authors: PHARMACOLOGY
Format: Article
Language:English
Published: ELSEVIER IRELAND LTD 2020
Subjects:
Science & Technology
Life Sciences & Biomedicine
Oncology
Panobinostat
Histone deacetylase inhibitors
LBH589
Non-small cell lung cancer
Epigenetic therapy
HISTONE DEACETYLASE INHIBITORS
DNA-DAMAGE
1ST-LINE TREATMENT
OPEN-LABEL
PHASE-I
CHEMOTHERAPY
MULTICENTER
ERLOTINIB
METAANALYSIS
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175506
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/175506

Similar Items